Cellebrite Operating Income Over Time
| CLBT Stock | USD 14.64 0.94 6.86% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cellebrite Performance and Cellebrite Correlation. Cellebrite | Build AI portfolio with Cellebrite Stock |
Is there potential for Application Software market expansion? Will Cellebrite introduce new products? Factors like these will boost the valuation of Cellebrite. Projected growth potential of Cellebrite fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Cellebrite listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.018 | Earnings Share 0.31 | Revenue Per Share | Quarterly Revenue Growth 0.181 | Return On Assets |
Cellebrite DI's market price often diverges from its book value, the accounting figure shown on Cellebrite's balance sheet. Smart investors calculate Cellebrite's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Cellebrite's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cellebrite's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cellebrite should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cellebrite's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Income Analysis
Compare Cellebrite DI and related stocks such as Varonis Systems, Navan Class A, and Dlocal Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VRNS | (1.2 M) | (3.4 M) | (1.6 M) | (5.8 M) | (17.3 M) | (19.1 M) | (15.7 M) | (13.4 M) | (29.1 M) | (76 M) | (78.4 M) | (107.6 M) | (121.2 M) | (117.2 M) | (106.8 M) | (146.5 M) | (139.2 M) |
| NAVN | (246.3 M) | (246.3 M) | (246.3 M) | (246.3 M) | (246.3 M) | (246.3 M) | (246.3 M) | (246.3 M) | (246.3 M) | (246.3 M) | (246.3 M) | (246.3 M) | (246.3 M) | (246.3 M) | (107.6 M) | (123.8 M) | (130 M) |
| DLO | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 17.6 M | 30.9 M | 83.8 M | 127.9 M | 179.7 M | 140.5 M | 161.6 M | 106.4 M |
| STNE | 134.4 M | 134.4 M | 134.4 M | 134.4 M | 134.4 M | 134.4 M | 134.4 M | 250.6 M | 702.7 M | 1.3 B | 1.4 B | 923.6 M | 3.5 B | 5.2 B | 5.9 B | 6.8 B | 7.1 B |
| DOCN | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (27.3 M) | (29.9 M) | (15.8 M) | (11.2 M) | (25.7 M) | 11.9 M | 91 M | 104.7 M | 109.9 M |
| QLYS | 1.1 M | 2.9 M | 3 M | 2.3 M | 9.2 M | 24.8 M | 30.1 M | 37.2 M | 50.4 M | 72.3 M | 96.7 M | 87.7 M | 130.5 M | 163.1 M | 187.2 M | 222 M | 233 M |
| VIA | 2.9 B | 3.6 B | 29.4 M | 32.8 M | (3.8 M) | 29.9 M | 84 M | 102.4 M | (3.7 M) | 24 M | 88.8 M | 4.4 M | 24.8 M | (114.5 M) | (83.9 M) | (75.5 M) | (71.7 M) |
| BOX | (109.1 M) | (109.1 M) | (109.1 M) | (158.8 M) | (166.7 M) | (201 M) | (150.7 M) | (154 M) | (134.2 M) | (139.5 M) | (37.6 M) | (27.6 M) | 36.8 M | 50.8 M | 79.6 M | 91.6 M | 96.2 M |
| COMP | (62.9 M) | (62.9 M) | (62.9 M) | (62.9 M) | (62.9 M) | (62.9 M) | (62.9 M) | (65.6 M) | (237.7 M) | (401.8 M) | (273.3 M) | (493 M) | (589.4 M) | (314.9 M) | (154.8 M) | (139.3 M) | (146.3 M) |
| WRD | (18.6 M) | (18.6 M) | (18.6 M) | (18.6 M) | (18.6 M) | (27.5 M) | (15.8 M) | 105.5 M | (463.9 M) | (463.9 M) | (463.9 M) | (500.5 M) | (779.2 M) | (1.6 B) | (2.2 B) | (2 B) | (1.9 B) |
Cellebrite DI and related stocks such as Varonis Systems, Navan Class A, and Dlocal Operating Income description
Operating Income is the amount of profit realized from Cellebrite DI operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Cellebrite DI is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Cellebrite DI | CLBT |
Specialization | Information Technology, Software - Infrastructure |
| Business Address | 94 Shlomo Shmelzer |
| Exchange | NASDAQ Exchange |
USD 14.64
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.